Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Korosho Study Group Issues GL on Terminal Care
April 30, 2007
- Generic Substitution Rate Remains "very Low" Despite New Prescription Form: Chuikyo
April 30, 2007
- Doctors' Average Monthly Salaries Up to \761,000
April 30, 2007
- Information on Incidence of ADRs Is Not Intellectual Property: PMDA's Mr Kishida
April 30, 2007
- Status of 5 Major Diseases in 2015 Surveyed: JHSF
April 30, 2007
- 29 New Drugs Approved
April 30, 2007
- Plavix to Drive Sales of sanofi-aventis in 2007: Mr Fauchet
April 30, 2007
- Expert Group Starts Discussing Compassionate Use of Unapproved Drugs
April 30, 2007
- Shionogi to Hire More MRs to Promote Crestor, Irbesartan
April 23, 2007
- Medical Spending Should Be Increased: JMA President
April 23, 2007
- Asahi Kasei to Focus on 3 Fields
April 23, 2007
- Strict Control of cholesterol Required in Hyperlipidemia Patients with Diabetes
April 23, 2007
- Explosion at Shin-Etsu Chemical Affects Supply of Cellulose Derivatives
April 23, 2007
- Early Treatment of Hepatitis C Needed to Prevent Liver Cancer
April 23, 2007
- System That Reduces Number of Quick Deliveries Needed: Mr Choufuku of Mediceo Paltac
April 23, 2007
- TOPICS／NOXAFIL Recommended for Antifungal Prophylaxis: Schering-Plough
April 23, 2007
- Korosho to Hear Wholesalers, Hospitals, Pharmacies Again Over Agreements on Prices
April 23, 2007
- Bayer Yakuhin to Integrate Nihon Schering in July: Dr Portoff
April 23, 2007
- BUSINESS NEWS IN BRIEF
April 23, 2007
- 27th General Assembly of the Japan Medical Congress
April 23, 2007
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…